Good morning :)
Place Order
Add to Watchlist

Advanced Enzyme Technologies Ltd

ADVENZYMES Share Price

338.250.09% (+0.30)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹3,784 cr, stock is ranked 881

Stock is 3.03x as volatile as Nifty

ADVENZYMES Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹3,784 cr, stock is ranked 881

Stock is 3.03x as volatile as Nifty

ADVENZYMES Performance & Key Metrics

ADVENZYMES Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
28.862.580.35%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
28.033.511.56%

ADVENZYMES Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

ADVENZYMES Company Profile

Advanced Enzyme Technologies is engaged in the research and development, manufacturing and marketing of over 400 products developed from over 60 indigenous enzymes.

Investor Presentation

View older View older 

May 13, 2025

PDF
View Older Presentations

ADVENZYMES Similar Stocks (Peers)

Compare with peers Compare with peers 

ADVENZYMES Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
70.85
70.85
1Y Return
8.54%
8.54%
Buy Reco %
55.56
55.56
PE Ratio
84.77
84.77
1Y Return
34.82%
34.82%
Buy Reco %
61.54
61.54
PE Ratio
49.75
49.75
1Y Return
0.11%
0.11%
Buy Reco %
83.33
83.33
PE Ratio
52.20
52.20
1Y Return
33.67%
33.67%
Buy Reco %
70.59
70.59
PE Ratio
39.36
39.36
1Y Return
0.87%
0.87%
Buy Reco %
70.00
70.00
Compare with Peers

ADVENZYMES Sentiment Analysis

ADVENZYMES Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

ADVENZYMES Stock Summary · May 2025

In Q4 FY '25, the company demonstrated a cautious optimism for future growth, reporting a 6% year-on-year increase despite a sequential decline in EBITDA margins due to product mix changes. Significant investments in R&D, now at 9.34% of revenue, underscore a commitment to innovation, while sustainability initiatives, including a solar power plant, enhance operational efficiency. However, challenges such as high debt levels, geopolitical tensions, and tariff impacts loom over the growth outlook, particularly in the U.S. and international markets. The company is strategically expanding its product portfolio and distribution networks to capitalize on positive trends in biocatalysts and specialized manufacturing, aiming for a high-single-digit growth trajectory in the coming years.

ADVENZYMES Stock Growth Drivers
ADVENZYMES Stock Growth Drivers
8
  • Sustainability Initiatives

    The company has made significant strides in sustainability by completing the installation of a 350-kilowatt

  • Financial Performance and Growth

    In Q4, the company reported a top line of INR 1,672 million, reflecting a 6%

ADVENZYMES Stock Challenges
ADVENZYMES Stock Challenges
5
  • Declining Financial Performance

    The company reported a decrease in revenue and profitability metrics across various segments. In Q4,

  • Challenges in Key Segments

    The Human Nutrition segment, which constitutes 62% of revenue, experienced a 3% annual decline due

ADVENZYMES Forecast

ADVENZYMES Forecasts

Price

Revenue

Earnings

ADVENZYMES

ADVENZYMES

Income

Balance Sheet

Cash Flow

ADVENZYMES Income Statement

ADVENZYMES Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 8.3%, vs industry avg of 11.47%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.87% to 0.72%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 0.28%, vs industry avg of 7.76%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue331.57392.41424.63449.63510.69535.80566.10660.53669.95669.95
Raw Materialssubtract70.1480.3365.9590.83100.21130.32127.53155.47161.96442.48
Power & Fuel Costsubtract12.8718.1019.2919.3721.4529.9538.1041.5138.45
Employee Costsubtract50.7068.6080.2380.1987.11103.96114.80127.78141.54
Selling & Administrative Expensessubtract25.6138.4140.0437.5837.7251.8056.2259.9664.17
Operating & Other expensessubtract18.0020.6430.8412.6522.7810.7750.5648.6335.28
Depreciation/Amortizationsubtract12.7618.3021.1225.7828.7234.9835.0335.2436.5636.56
Interest & Other Itemssubtract4.439.065.204.082.572.963.484.124.633.55
Taxes & Other Itemssubtract45.5148.9150.9049.8764.2151.4834.7554.5256.2656.24
EPS2.798.079.9511.5813.0610.709.4511.9211.7211.72
DPS0.080.500.600.600.901.001.005.101.205.10
Payout ratio0.030.060.060.050.070.090.110.430.100.44

ADVENZYMES Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 13PDF
Feb 8PDF
Nov 9PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 12PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 13PDF
Feb 11PDF
Nov 11PDF
Aug 6PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

May 20PDF
Feb 5PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

ADVENZYMES Stock Peers

ADVENZYMES Past Performance & Peer Comparison

ADVENZYMES Past Performance & Peer Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Advanced Enzyme Technologies Ltd28.872.580.35%
Gujarat Fluorochemicals Ltd70.856.520.09%
Navin Fluorine International Ltd84.7710.270.24%
Vinati Organics Ltd49.758.190.39%

ADVENZYMES Stock Price Comparison

Compare ADVENZYMES with any stock or ETF
Compare ADVENZYMES with any stock or ETF
ADVENZYMES
Loading...

ADVENZYMES Holdings

ADVENZYMES Shareholdings

ADVENZYMES Promoter Holdings Trend

ADVENZYMES Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

ADVENZYMES Institutional Holdings Trend

ADVENZYMES Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

ADVENZYMES Shareholding Pattern

ADVENZYMES Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding43.08%5.36%2.83%11.90%36.83%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

ADVENZYMES Shareholding History

ADVENZYMES Shareholding History

Dec '23MarJunSepDec '24Mar22.54%23.01%12.03%12.63%12.58%11.90%

Mutual Funds Invested in ADVENZYMES

Mutual Funds Invested in ADVENZYMES

No mutual funds holding trends are available

Top 5 Mutual Funds holding Advanced Enzyme Technologies Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
2.0691%1.42%0.01%21/47 (-1)
0.8817%1.16%0.10%33/56 (+1)
0.7030%1.74%0.07%17/53 (+2)

Compare 3-month MF holding change on Screener

ADVENZYMES Insider Trades & Bulk Stock Deals

ADVENZYMES Insider Trades & Bulk Stock Deals

Loading...

smallcases containing ADVENZYMES stock

smallcases containing ADVENZYMES stock

Looks like this stock is not in any smallcase yet.

ADVENZYMES Events

ADVENZYMES Events

ADVENZYMES Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

ADVENZYMES Dividend Trend

No dividend trend available

ADVENZYMES Upcoming Dividends

ADVENZYMES Upcoming Dividends

Cash Dividend

Ex DateEx DateJul 23, 2025

Final
Final | Div/Share: ₹1.20

Dividend/Share

1.20

Ex DateEx Date

Jul 23, 2025

ADVENZYMES Past Dividends

ADVENZYMES Past Dividends

Cash Dividend

Ex DateEx DateMay 16, 2025

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

May 16, 2025

Cash Dividend

Ex DateEx DateJul 18, 2024

Final
Final | Div/Share: ₹1.10

Dividend/Share

1.10

Ex DateEx Date

Jul 18, 2024

Cash Dividend

Ex DateEx DateMay 17, 2024

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

May 17, 2024

Cash Dividend

Ex DateEx DateAug 4, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Aug 4, 2023

Cash Dividend

Ex DateEx DateMay 19, 2023

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

May 19, 2023

ADVENZYMES Stock News & Opinions

ADVENZYMES Stock News & Opinions

Corporate
Advanced Enzyme Technologies fixes record date for interim dividend

Advanced Enzyme Technologies has fixed 17 May 2025 as record date for payment of interim dividend of Rs 4 per equity share for FY 2025-26. The dividend will be paid on or before 10 June 2025. Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to convene AGM

Advanced Enzyme Techs. announced that the 36th Annual General Meeting(AGM) of the company will be held on 30 July 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of Advanced Enzyme Techs. recommends final dividend

Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting held on 13 May 2025, inter alia, have recommended the final dividend of Rs 1.2 per equity Share (i.e. 60%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of Advanced Enzyme Techs. recommends interim dividend

Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting held on 13 May 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 200%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Advanced Enzyme Technologies consolidated net profit declines 6.46% in the March 2025 quarter

Net profit of Advanced Enzyme Technologies declined 6.46% to Rs 26.48 crore in the quarter ended March 2025 as against Rs 28.31 crore during the previous quarter ended March 2024. Sales rose 5.93% to Rs 167.18 crore in the quarter ended March 2025 as against Rs 157.82 crore during the previous quarter ended March 2024. For the full year,net profit declined 1.64% to Rs 131.12 crore in the year ended March 2025 as against Rs 133.31 crore during the previous year ended March 2024. Sales rose 2.09% to Rs 636.91 crore in the year ended March 2025 as against Rs 623.87 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales167.18157.82 6 636.91623.87 2 OPM %27.2835.08 -30.5332.77 - PBDT53.5464.02 -16 223.92238.19 -6 PBT43.4654.74 -21 187.36202.95 -8 NP26.4828.31 -6 131.12133.31 -2 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to declare Quarterly Results

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 13 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to declare Quarterly Results

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 13 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Advanced Enzyme Technologies allots 500 equity shares under ESOS

Advanced Enzyme Technologies has allotted 500 equity shares under ESOS on 19 March 2025. Consequent to the said allotment, the paid-up share capital of the Company stands increased from Rs 22,37,61,300 comprising of 11,18,80,650 equity shares of Rs 2 each to Rs 22,37,62,300 comprising of 11,18,81,150 equity shares of Rs 2 each. Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Advanced Enzyme Technologies consolidated net profit declines 9.86% in the December 2024 quarter

Net profit of Advanced Enzyme Technologies declined 9.86% to Rs 37.65 crore in the quarter ended December 2024 as against Rs 41.77 crore during the previous quarter ended December 2023. Sales rose 5.08% to Rs 169.11 crore in the quarter ended December 2024 as against Rs 160.94 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales169.11160.94 5 OPM %32.6733.40 - PBDT61.9967.48 -8 PBT53.0258.88 -10 NP37.6541.77 -10 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to announce Quarterly Result

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 8 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Advanced Enzyme Technologies Ltd (ADVENZYMES) today?

    The share price of ADVENZYMES as on 4th July 2025 is ₹338.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Advanced Enzyme Technologies Ltd (ADVENZYMES) share?

    The past returns of Advanced Enzyme Technologies Ltd (ADVENZYMES) share are
    • Past 1 week: 3.57%
    • Past 1 month: 11.17%
    • Past 3 months: 21.69%
    • Past 6 months: -1.96%
    • Past 1 year: -15.16%
    • Past 3 years: 28.73%
    • Past 5 years: 98.15%

  3. What are the peers or stocks similar to Advanced Enzyme Technologies Ltd (ADVENZYMES)?
  4. What is the dividend yield % of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?

    The current dividend yield of Advanced Enzyme Technologies Ltd (ADVENZYMES) is 0.35.

  5. What is the market cap of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹3784.38 Cr as of 4th July 2025.

  6. What is the 52 week high and low of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?

    The 52-week high of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹571 and the 52-week low is ₹257.90.

  7. What is the PE and PB ratio of Advanced Enzyme Technologies Ltd (ADVENZYMES) stock?

    The P/E (price-to-earnings) ratio of Advanced Enzyme Technologies Ltd (ADVENZYMES) is 28.87. The P/B (price-to-book) ratio is 2.58.

  8. Which sector does Advanced Enzyme Technologies Ltd (ADVENZYMES) belong to?

    Advanced Enzyme Technologies Ltd (ADVENZYMES) belongs to the Materials sector & Specialty Chemicals sub-sector.

  9. How to buy Advanced Enzyme Technologies Ltd (ADVENZYMES) shares?

    You can directly buy Advanced Enzyme Technologies Ltd (ADVENZYMES) shares on Tickertape. Simply sign up, connect your demat account and place your order.